In addition to immunomodulation, CRP is also used as a marker for disease prognosis in conditions such as post-myocardial infarction management, where patients with higher levels of CRP at discharge are more likely to have a history of unstable angina and have symptom onset at lower levels of activity. Here, CRP is linked to angina pectoris.